(Q44522282)

English

Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat.

scientific article published in August 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Kazuaki Takamori

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Shiho Hirota

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Shigeyuki Chaki

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Makoto Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1721-1728

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Loss of discriminative avoidance behavior by local application of kynurenic acid into the nucleus accumbens of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Effect of nucleus accumbens destruction in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Antagonism by locally applied dopamine into the nucleus accumbens or the corpus striatum of alpha-methyltyrosine-induced disruption of conditioned avoidance behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Haloperidol-induced morphological changes in striatum are associated with glutamate synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

From motivation to action: functional interface between the limbic system and the motor system.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Differential involvement of dopamine in the shell and core of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Molecular diversity and functions of glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Trans-ACPD and L-APB presynaptically inhibit excitatory glutamatergic transmission in the basolateral amygdala (BLA).

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Antipsychotic profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Metabotropic glutamate receptors in brain function and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Metabotropic glutamate group II receptors are responsible for the depression of synaptic transmission induced by ACPD in the dentate gyrus

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

A rapidly acquired one-way conditioned avoidance procedure in rats as a primary screening test for antipsychotics: influence of shock intensity on avoidance performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900509-5

7 January 2021

Identifiers

10.1016/S0024-3205(03)00509-5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44522282&oldid=1375522298"